Chemistry & immunochemistry

More Offers

Snibe Diagnostic

Maglumi SARS-CoV-2 Neutralizing Antibody (CLIA)

Highlights:
Addressing the urgent need of assessing immunity during the COVID-19 pandemic

  • An important tool of the COVID-19 vaccine efficacy assessment
  • Evaluating immunity in individuals and community to provide immunity “certification” for returning to society
  • Cost-effective and large-scale solution for neutralizing antibody test
  • Highly sensitive and specific detection of neutralizing antibodies: 100 percent positive agreement to gold standard

Snibe Diagnostic

No.23, Jinxiu East Road
518122 Shenzhen
China

Related products

Snibe – Molecision SARS-CoV-2 RT-PCR Assay

Infectious Disease

Snibe – Molecision SARS-CoV-2 RT-PCR Assay

Snibe Diagnostic
Snibe – Molecision MP-96

Extraction

Snibe – Molecision MP-96

Snibe Diagnostic
Snibe – Maglumi X8

Immunoassays

Snibe – Maglumi X8

Snibe Diagnostic
Snibe - Maglumi X3

Immunoassays

Snibe - Maglumi X3

Snibe Diagnostic
Snibe – Molecision MP-32

Extraction

Snibe – Molecision MP-32

Snibe Diagnostic
Snibe - Biossays E6

Clinical Chemistry

Snibe - Biossays E6

Snibe Diagnostic
Subscribe to Newsletter